Effect and mechanism of berberine-targeted regulation of TLR4 signaling pathway on the biological behaviour of malignant melanoma
-
摘要:
目的 探讨黄连素对恶性黑色素瘤Toll样受体4(TLR4)信号通路的调节作用,评估其对脂多糖(LPS)诱导的恶性黑色素瘤A375细胞增殖、迁移、凋亡的影响,为防治恶性黑色素瘤提供新的药物(黄连素)治疗依据。 方法 采用Western blotting法检测不同浓度黄连素对A375细胞TLR4、核因子κB(NF-κB)表达的干预作用。实验分组:A组为对照组;B组为LPS组;C组为TAK-242组;D组为LPS+TAK-242组;E组为LPS+TAK-242+80 μmol/L黄连素组;F组为LPS+TAK-242+120 μmol/L黄连素组。采用CCK-8、Transwell、流式细胞术检测黄连素靶向TLR4对A375增殖、迁移、凋亡的作用;采用酶联免疫吸附实验(ELISA)检测每组细胞上清中白介素-10(IL-10)和转化生长因子β(TGF-β)表达的影响。 结果 黄连素浓度升高,TLR4、NF-κB蛋白表达量下调越明显(均P<0.05)。与A组比较,B组增殖、迁移能力增强,凋亡无差异;C组增殖、迁移能力减弱,凋亡增加;D组增殖、迁移能力相较B组减弱,相较C组增强;与D组比较,E、F组增殖、迁移能力减弱,凋亡增加。黄连素在高浓度时细胞的增殖、迁移能力减弱更明显(均P<0.05)。B组IL-10与TGF-β的表达水平增加(均P<0.05);C组IL-10的表达水平降低,TGF-β的表达无显著变化;D组IL-10相较B组降低,相较C组增加;F组IL-10和TGF-β的表达水平显著降低(均P<0.05)。 结论 黄连素通过抑制TLR4/NF-κB信号通路抑制LPS诱导的恶性黑色素瘤细胞增殖、迁移,促进其凋亡。黄连素或可作为治疗恶性黑色素瘤的药物。 Abstract:Objective To explore the regulatory effect of berberine on the TLR4 signaling pathway in malignant melanoma, to evaluate its effect on the proliferation, migration, and apoptosis of malignant melanoma A375 cells induced by lipopolysaccharide (LPS), and to provide a new drug (berberine) treatment basis for the prevention and treatment of malignant melanoma. Methods Western blotting was used to detect the intervention effects of different concentrations of berberine on the expression of TLR4 and NF-κB in A375 cells. The experimental groups were as follows: group A was control group, group B was LPS group, group C was TAK-242 group, group D was LPS+TAK-242 group, group E was LPS+TAK-242+80 μmol/L berberine group, and group F was LPS+TAK-242+120 μmol/L Berberine group. CCK-8, Transwell and flow cytometry assays were used to detect the effects of berberine targeting TLR4 on the proliferation, migration, and apoptosis of A375. We used enzyme-linked immunosorbent assay to detect the expression of IL-10 and TGF-β in the supernatant of each group of cell influences. Results With increased concentration of berberine, the expression of TLR4 and NF-κB protein was down-regulated more significantly (all P < 0.05). Compared with group A, the proliferation and migration ability of group B was enhanced, but no difference existed in apoptosis. The proliferation and migration ability of group C was weakened, and apoptosis was increased. The proliferation and migration ability of group D was weaker than that of group B and stronger than that of group C. Compared with group D, the proliferation and migration ability of E and F groups weakened, and apoptosis increased. At high concentrations of berberine, the cell proliferation and migration ability weakened more obviously (all P < 0.05). The expression levels of IL-10 and TGF-β in group B increased (all P < 0.05), the expression level of IL-10 in group C decreased, and the expression of TGF-β did not change significantly. The IL-10 of group D was lower than that of group B and increased compared with that of group C. The expression levels of IL-10 and TGF-β in group F were significantly reduced (all P < 0.05). Conclusion Berberine inhibits the proliferation and migration of LPS-induced malignant melanoma cells and promotes their apoptosis by inhibiting the TLR4/NF-κB signaling pathway. Berberine may be used as a medicine to treat malignant melanoma. -
Key words:
- Berberine /
- Melanoma cells /
- Proliferation /
- Migration /
- Apoptosis /
- Toll-like receptor 4
-
表 1 黄连素靶向TLR4/NF-κB对A375细胞相对增殖率的影响(x ±s,%)
组别 相对增殖率 24 h 48 h A组 1.80±0.04 5.01±0.52 B组 2.04±0.03 5.58±0.59a C组 1.38±0.23 2.13±0.63a D组 1.61±0.14 2.55±0.56a E组 1.36±0.04 1.85±0.07b F组 1.32±0.05 1.56±0.18b 注:与A组比较,aP < 0.05;与D组比较,bP < 0.05。 -
[1] TODO Y, OKAMOTO K, SUZUKI Y, et al. Radicality of initial surgery for primary malignant melanoma of the vagina[J]. Melanoma Res, 2016, 26(2): 173-180. doi: 10.1097/CMR.0000000000000239 [2] OHADIAN MOGHADAM S, NOWROOZI M R. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy[J]. Scand J Immunol, 2019, 90(6): e12818. [3] KHADEMALHOSSEINI M, ARABABADI M K. Toll-like receptor 4 and breast cancer: An updated systematic review[J]. Breast Cancer, 2019, 26(3): 265-271. doi: 10.1007/s12282-018-00935-2 [4] KHEDR L H, NASSAR N N, RASHED L, et al. TLR4 signaling modulation of PGC1-α mediated mitochondrial biogenesis in the LPS-Chronic mild stress model: Effect of fluoxetine and pentoxiyfylline[J]. Life Sci, 2019, 239: 116869. doi: 10.1016/j.lfs.2019.116869 [5] LI M, ZHANG M, ZHANG Z L, et al. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB[J]. Oncol Res, 2017, 25(2): 233-239. doi: 10.3727/096504016X14742891049073 [6] TAN W, ZHONG Z, WANG S, et al. Berberine regulated lipid metabolism in the presence of C75, compound C, and TOFA in breast cancer cell line MCF-7[J]. Evid Based Complement Alternat Med, 2015, 2015: 396035. [7] ZHU W, ZOU B, WANG S. Clinicopathological features and prognosis of sinonasal mucosal malignant melanoma: A retrospective study of 83 cases in a Chinese population[J]. ORL J Otorhinolaryngol Relat Spec, 2016, 78(2): 94-104. doi: 10.1159/000444500 [8] LEE A J, RO M, CHO K J, et al. Lipopolysaccharide/TLR4 stimulates IL-13 production through a MyD88-BLT2-Linked cascade in mast cells, potentially contributing to the allergic response[J]. J Immunol, 2017, 199(2): 409-417. doi: 10.4049/jimmunol.1602062 [9] ZHOU S, DU R, WANG Z, et al. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma[J]. Cancer Med, 2019, 8(5): 2325-2337. doi: 10.1002/cam4.2070 [10] MIKAMI E, KUDO M, OHASHI R, et al. Toll-like receptor 4 plays a tumor-suppressive role in cutaneous squamous cell carcinoma[J]. Int J Oncol, 2019, 54(6): 2179-2188. [11] MOSER V A, UCHOA M F, PIKE C J. TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity[J]. J Neuroinflammation, 2018, 15(1): 306. doi: 10.1186/s12974-018-1340-0 [12] SU C, LIU C, ZHAO L, et al. Amide proton transfer imaging allows detection of glioma grades and tumor proliferation: Comparison with Ki-67 expression and proton MR spectroscopy imaging[J]. AJNR Am J Neuroradiol, 2017, 38(9): 1702-1709. doi: 10.3174/ajnr.A5301 [13] DILLON C P, GREEN D R. Molecular cell biology of apoptosis and necroptosis in cancer[J]. Adv Exp Med Biol, 2016, 930: 1-23. [14] LV Z, LIU M, SHEN J, et al. Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases[J]. Exp Ther Med, 2018, 15(6): 5475-5480. [15] GOLAN T, PARIKH R, JACOB E, et al. Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211[J]. Sci Signal, 2019, 12(591): eaav6847. DOI: 10.1126/scisignal.aav6847.